Ginsenoside Re reduces Aβ production by activating PPARγ to inhibit BACE1 in N2a/APP695 cells.
暂无分享,去创建一个
Yuexia Liang | Shuai Zhang | Wenshen Zhang | P. Su | Haijing Zhang | Limin Guo | Chunxia Qin | Guoqiong Cao
[1] A. Tramutola,et al. Oxidative stress, protein modification and Alzheimer disease , 2017, Brain Research Bulletin.
[2] M. Ohno. Alzheimer’s therapy targeting the β-secretase enzyme BACE1: Benefits and potential limitations from the perspective of animal model studies , 2016, Brain Research Bulletin.
[3] Chun Li,et al. Traditional uses, botany, phytochemistry, pharmacology and toxicology of Panax notoginseng (Burk.) F.H. Chen: A review. , 2016, Journal of ethnopharmacology.
[4] S. Hsieh,et al. Effects of Panax notoginseng on the Metastasis of Human Colorectal Cancer Cells. , 2016, The American journal of Chinese medicine.
[5] Z. Deng,et al. Proteomic analysis of ginsenoside Re attenuates hydrogen peroxide-induced oxidative stress in human umbilical vein endothelial cells. , 2016, Food & function.
[6] Takafumi Inoue,et al. PPARγ agonist pioglitazone improves cerebellar dysfunction at pre-Aβ deposition stage in APPswe/PS1dE9 Alzheimer's disease model mice. , 2016, Biochemical and biophysical research communications.
[7] Jing Zhang,et al. Tripchlorolide Attenuates β-amyloid Generation via Suppressing PPARγ-Regulated BACE1 Activity in N2a/APP695 Cells , 2016, Molecular Neurobiology.
[8] Zheng-Tao Wang,et al. [Structure and biological action on cardiovascular systems of saponins from Panax notoginseng]. , 2015, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.
[9] A. Pan,et al. Effects of total saponins of Panax notoginseng on immature neuroblasts in the adult olfactory bulb following global cerebral ischemia/reperfusion , 2015, Neural regeneration research.
[10] Wenshen Zhang,et al. Protective Effect of Notoginsenoside R1 on an APP/PS1 Mouse Model of Alzheimer's Disease by Up-Regulating Insulin Degrading Enzyme and Inhibiting Aβ Accumulation. , 2015, CNS & neurological disorders drug targets.
[11] R. Bauer,et al. Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review , 2014, Biochemical pharmacology.
[12] Yitao Wang,et al. Saponins of Panax notoginseng: chemistry, cellular targets and therapeutic opportunities in cardiovascular diseases , 2014, Expert opinion on investigational drugs.
[13] Yan Liu,et al. Ginsenoside Rg1 attenuates okadaic acid induced spatial memory impairment by the GSK3β/tau signaling pathway and the Aβ formation prevention in rats. , 2013, European journal of pharmacology.
[14] Hailong Zhang,et al. Ginsenoside Re reduces insulin resistance through activation of PPAR-γ pathway and inhibition of TNF-α production. , 2013, Journal of ethnopharmacology.
[15] Qian-kun Quan,et al. Ginsenoside Rg1 Decreases Aβ1–42 Level by Upregulating PPARγ and IDE Expression in the Hippocampus of a Rat Model of Alzheimer's Disease , 2013, PloS one.
[16] M. Sathya,et al. BACE1 in Alzheimer's disease. , 2012, Clinica chimica acta; international journal of clinical chemistry.
[17] So-Young Jung,et al. Effects of ginsenoside Re on LPS-induced inflammatory mediators in BV2 microglial cells , 2012, BMC Complementary and Alternative Medicine.
[18] I. Cho. Effects of Panax ginseng in Neurodegenerative Diseases , 2012, Journal of ginseng research.
[19] Rachna Gupta,et al. Improvement in long term and visuo-spatial memory following chronic pioglitazone in mouse model of Alzheimer's disease , 2012, Pharmacology Biochemistry and Behavior.
[20] G. Landreth,et al. Mechanisms Underlying the Rapid Peroxisome Proliferator-Activated Receptor-γ-Mediated Amyloid Clearance and Reversal of Cognitive Deficits in a Murine Model of Alzheimer's Disease , 2012, The Journal of Neuroscience.
[21] Jin-Lan Huang,et al. [Effect of Panax notoginseng saponins on expression of alpha-secretase mRNA in brains of senescence-accelerated SAMP8 mice]. , 2012, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.
[22] Jing Zhang,et al. Ginsenoside Rg1 attenuates β-amyloid generation via suppressing PPARγ-regulated BACE1 activity in N2a-APP695 cells. , 2012, European journal of pharmacology.
[23] G. Landreth,et al. Nuclear receptors as therapeutic targets for Alzheimer's disease , 2011, Expert opinion on therapeutic targets.
[24] P. Williams,et al. Natural products as a source of Alzheimer's drug leads. , 2011, Natural product reports.
[25] Jianfang Ma,et al. Salidroside attenuates hypoxia-induced abnormal processing of amyloid precursor protein by decreasing BACE1 expression in SH-SY5Y cells , 2010, Neuroscience Letters.
[26] A. García-Osta,et al. Rosiglitazone Rescues Memory Impairment in Alzheimer's Transgenic Mice: Mechanisms Involving a Reduced Amyloid and Tau Pathology , 2010, Neuropsychopharmacology.
[27] S. Pimplikar,et al. Reassessing the amyloid cascade hypothesis of Alzheimer's disease. , 2009, The international journal of biochemistry & cell biology.
[28] E. Hellström‐Lindahl,et al. Nicotinic receptor agonists and antagonists increase sAPPα secretion and decrease Aβ levels in vitro , 2009, Neurochemistry International.
[29] Xiaomian Zhou,et al. Neuroprotection of ginsenoside Re in cerebral ischemia–reperfusion injury in rats , 2008, Journal of Asian natural products research.
[30] F. Checler,et al. NFκB-dependent Control of BACE1 Promoter Transactivation by Aβ42* , 2008, Journal of Biological Chemistry.
[31] K. Tsim,et al. Ginsenoside Re attenuate beta-amyloid and serum-free induced neurotoxicity in PC12 cells. , 2006, Journal of ethnopharmacology.
[32] C. Eckman,et al. Reductions in levels of the Alzheimer's amyloid β peptide after oral administration of ginsenosides , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[33] S. Craft,et al. Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice , 2006, Experimental Neurology.
[34] T. Klockgether,et al. Nonsteroidal anti-inflammatory drugs repress beta-secretase gene promoter activity by the activation of PPARgamma. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[35] Jae-Kwan Hwang,et al. Ginsenoside 20(S)-Protopanaxatriol (PPT) activates peroxisome proliferator-activated receptor γ (PPARγ) in 3T3-L1 adipocytes , 2006 .
[36] Zhongpeng Lu,et al. [Protective effects of Panax notoginseng saponins against pathological lesion of cholinergic neuron in rat model with Alzheimer' s disease]. , 2005, Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials.
[37] Hong Qing,et al. Transcriptional Regulation of BACE1, the β-Amyloid Precursor Protein β-Secretase, by Sp1 , 2004, Molecular and Cellular Biology.